Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
EFC10547
Phase 3 small_molecule terminated
Quick answer
Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®) for Pancreatic Neoplasm is a Phase 3 program (small_molecule) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Pancreatic Neoplasm
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated